GSK P/E ratio: current value, 10-year range and year-by-year history
Cash & Leverage
GSK's p/e ratio is right around its 10-year median of 15.1.
P/E ratio History
GSK P/E ratio by year
Yearly range of GSK’s p/e ratio from 2016 to 2026. Over the full period it ranged from 3.5 to 1,665.0, averaging 32.1.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 12.8 | 14.7 | 17.1 | 15.0 |
| 2025 | 12.1 | 18.2 | 25.4 | 13.2 |
| 2024 | 12.3 | 17.1 | 25.6 | 21.9 |
| 2023 | 3.5 | 5.3 | 10.2 | 9.8 |
| 2022 | 3.8 | 11.6 | 16.3 | 4.2 |
| 2021 | 8.4 | 11.9 | 15.3 | 14.9 |
| 2020 | 8.2 | 11.2 | 15.9 | 9.4 |
| 2019 | 14.3 | 15.6 | 17.5 | 15.3 |
| 2018 | 16.3 | 41.0 | 60.6 | 16.3 |
| 2017 | 22.1 | 39.2 | 69.3 | 22.6 |
| 2016 | 178.2 | 450.4 | 1,665.0 | 183.5 |
Get notified when GSK P/E ratio crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.
Price / Earnings Per ShareThe chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.
- Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
- A falling P/E trend may signal a business in structural decline, not a buying opportunity.
Is GSK P/E ratio High or Low Right Now?
GSK plc's P/E ratio is currently 15.0, which is around average relative to its 10-year historical range. The 10-year median P/E ratio for GSK is approximately 15.1. See all GSK valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.